HMPL-760

N/A

Report date: 2026/04/06 20:01:48
NME

Base Information

Drug NameHMPL-760
Drug Alias NameHMPL-760HMPL760
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBTK C481S inhibitors
TargetsBTK C481S
Therapy Area/IndicationsRichter's SyndromeWaldenstrom MacroglobulinemiaLymphoma, Follicular +[9
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandItaly +[8
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesHutchison Medipharma Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsLymphoma, Large B-Cell, DiffuseLymphoma, B-CellLymphoma, Non-Hodgkin
Inactive IndicationsRichter's SyndromeWaldenstrom MacroglobulinemiaLymphoma, Follicular +[6

Other Information

ATC CodeN/A
Related LinksN/A